BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10470103)

  • 1. 1H magnetic resonance spectroscopy evidence that aberrant crypt foci are preneoplastic lesions in the colon.
    Krupnik E; Brière KM; Bird RP; Littman C; Smith IC
    Anticancer Res; 1999; 19(3A):1699-703. PubMed ID: 10470103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
    Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
    J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
    Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
    Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
    Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
    Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalpa seed oil rich in 9t,11t,13c-conjugated linolenic acid suppresses the development of colonic aberrant crypt foci induced by azoxymethane in rats.
    Suzuki R; Yasui Y; Kohno H; Miyamoto S; Hosokawa M; Miyashita K; Tanaka T
    Oncol Rep; 2006 Nov; 16(5):989-96. PubMed ID: 17016582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalent location of flat dysplastic aberrant crypt foci near lymphoid follicles in the colon of azoxymethane-treated rats.
    Paulsen JE; Steffensen IL; Olstørn HB; Alexander J
    Anticancer Res; 2006; 26(3A):1803-7. PubMed ID: 16827110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis.
    Papanikolaou A; Wang QS; Papanikolaou D; Whiteley HE; Rosenberg DW
    Carcinogenesis; 2000 Aug; 21(8):1567-72. PubMed ID: 10910960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
    Rao CV; Hirose Y; Indranie C; Reddy BS
    Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemopreventive effect of a probiotic preparation on the development of preneoplastic and neoplastic colonic lesions: an experimental study.
    Marotta F; Naito Y; Minelli E; Tajiri H; Bertuccelli J; Wu CC; Min CH; Hotten P; Fesce E
    Hepatogastroenterology; 2003; 50(54):1914-8. PubMed ID: 14696432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer.
    Bird RP
    Cancer Lett; 1995 Jun; 93(1):55-71. PubMed ID: 7600544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis.
    Femia AP; Dolara P; Caderni G
    Carcinogenesis; 2004 Feb; 25(2):277-81. PubMed ID: 14604897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correspondence between flat aberrant crypt foci and mucin-depleted foci in rodent colon carcinogenesis.
    Femia AP; Paulsen JE; Dolara P; Alexander J; Caderni G
    Anticancer Res; 2008; 28(6A):3771-5. PubMed ID: 19189663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of resistant starch on colonic preneoplastic aberrant crypt foci in rats.
    Liu R; Xu G
    Food Chem Toxicol; 2008 Aug; 46(8):2672-9. PubMed ID: 18571825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
    Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flax seed oil and flax seed meal reduce the formation of aberrant crypt foci (ACF) in azoxymethane-induced colon cancer in Fisher 344 male rats.
    Williams D; Verghese M; Walker LT; Boateng J; Shackelford L; Chawan CB
    Food Chem Toxicol; 2007 Jan; 45(1):153-9. PubMed ID: 17045379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells.
    Raju J; Patlolla JM; Swamy MV; Rao CV
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of colon cancer by pre- and probiotics: evidence from laboratory studies.
    Reddy BS
    Br J Nutr; 1998 Oct; 80(4):S219-23. PubMed ID: 9924288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous development of aberrant crypt foci in F344 rats.
    Furukawa F; Nishikawa A; Kitahori Y; Tanakamaru Z; Hirose M
    J Exp Clin Cancer Res; 2002 Jun; 21(2):197-201. PubMed ID: 12148578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis.
    Caderni G; Femia AP; Giannini A; Favuzza A; Luceri C; Salvadori M; Dolara P
    Cancer Res; 2003 May; 63(10):2388-92. PubMed ID: 12750256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.